Substance Use Disorder Statistics in US 2026 | Key Facts

Substance Use Disorder in America 2026

Substance use disorder (SUD) is a complex, chronic brain condition in which a person’s use of one or more substances — alcohol, opioids, marijuana, stimulants, or other drugs — leads to significant impairment in their daily functioning, health, relationships, and ability to meet responsibilities. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defines SUD as a pattern of substance use resulting in clinically significant distress or impairment, measured across eleven diagnostic criteria including cravings, loss of control, continued use despite harm, and withdrawal. Far from being a moral failing or a simple lifestyle choice, SUD is now firmly recognized by the National Institute on Drug Abuse (NIDA) and the broader medical community as a treatable brain disorder, one that responds to evidence-based interventions including behavioral therapy, peer support, and medication-assisted treatment. In America, this condition touches millions of people across every state, income bracket, race, and age group, making it one of the most pervasive public health emergencies of our time.

As of 2026, substance use disorder in the United States remains a defining national health crisis, but one that is also showing meaningful signs of improvement in select areas. The most authoritative data available — drawn from the 2024 National Survey on Drug Use and Health (NSDUH), published by the Substance Abuse and Mental Health Services Administration (SAMHSA) in 2025, and supplemental Centers for Disease Control and Prevention (CDC) mortality data — paints a picture of a nation still bearing enormous burden but beginning to turn a corner. Drug overdose deaths declined nearly 27% in 2024, a historic drop. Yet 48.4 million Americans aged 12 or older — roughly 1 in 6 — still met diagnostic criteria for SUD in the past year, and 80% of those who needed substance use treatment did not receive it. These numbers are not statistics alone — they represent families fractured, careers derailed, and communities strained under the weight of an epidemic that demands both urgent policy action and compassionate, evidence-backed care.

Interesting Key Facts About Substance Use Disorder in the US 2026

The table below captures the most striking and important facts about substance use disorder drawn from verified U.S. government data. These figures represent the most recent confirmed statistics as of the latest federal publications.

Source: SAMHSA, 2024 National Survey on Drug Use and Health (NSDUH), published 2025; CDC National Center for Health Statistics (NCHS), Provisional Drug Overdose Death Data, 2025–2026; NIDA, Trends & Statistics

These key facts immediately make clear both the staggering scale of substance use disorder in America and the critical gap between need and access to care. 1 in 6 Americans living with SUD, over 80,000 overdose deaths in a single year, and a treatment gap that leaves 4 out of 5 people without help — these are numbers that demand attention. Yet the data also carry genuine hope: recovery rates are high when people access treatment, overdose deaths have dropped dramatically, and federal investment in behavioral health continues to grow.

When you look at the recovery statistic — that 74.3% of adults who felt they ever had a substance use problem now consider themselves in recovery — it reframes the narrative entirely. SUD is survivable. Treatment works. The challenge is getting more people through the door.

Overall Substance Use Disorder Prevalence in the US 2026

SUD Prevalence by Type — United States 2024

Source: SAMHSA, 2024 National Survey on Drug Use and Health (NSDUH), HHS Publication No. PEP25-07-007, released 2025

The overall prevalence of substance use disorder in America tells a nuanced story. While the headline figure of 48.4 million Americans with a past-year SUD may seem alarming, and rightly so, a closer look at the trend lines reveals mixed signals. On the positive side, alcohol use disorder declined from 10.6% to 9.7% between 2021 and 2024, which is statistically significant and reflects both changing drinking patterns and improved awareness. However, drug use disorder increased from 8.7% to 9.8% over the same period — driven largely by rising marijuana use disorder, now the single most common drug SUD at 20.6 million people. Marijuana’s increasing social acceptance and legal availability across many states appears to be contributing to this rise. It is also worth noting that approximately 7.7 million people — or roughly 1 in 6 of those with any SUD — are battling both an alcohol use disorder and a drug use disorder simultaneously, compounding the complexity of treatment needs.

What this data reveals at a systemic level is that substance use disorder in the United States cannot be reduced to a single substance or a single demographic. The disorder spans alcohol, drugs, and combinations of both, and it affects tens of millions of people. Any meaningful national response must address the full spectrum of SUD, including the growing burden of marijuana-related disorders that are often dismissed by the public as less serious than those involving opioids or alcohol.

Drug Overdose Deaths and Mortality Statistics in the US 2026

Provisional Drug Overdose Deaths — United States 2022–2024

Source: CDC National Center for Health Statistics (NCHS), NCHS Data Briefs 522 and 549; CDC Overdose Prevention Data Resources, March 2026; CDC NCHS Press Release, May 2025

The drug overdose death statistics for 2024 represent perhaps the most encouraging development in the U.S. substance use disorder landscape in decades. After drug overdose deaths peaked at approximately 110,000 in 2023, provisional data from the CDC’s National Vital Statistics System shows a decline to approximately 80,391 deaths in 2024 — a 26.9% year-over-year drop, which CDC officials have described as unprecedented. The largest improvements came from declines in deaths involving synthetic opioids (primarily fentanyl), which fell from roughly 83,140 opioid-involved deaths in 2023 to 54,743 in 2024. This decline was observed in 45 of the 50 states, with states like Louisiana, Michigan, West Virginia, Ohio, and Virginia recording drops of 35% or more. Early 2026 data continues this downward trajectory, with predicted overdose deaths for the 12 months ending October 2025 estimated at approximately 71,542 — a further 17.1% decline.

However, drug overdose still remains the leading cause of death for Americans aged 18 to 44, which underscores that even in a period of improvement, the crisis has not ended. States like South Dakota and Nevada continue to see increases, highlighting the uneven geographic distribution of the epidemic. 91.6% of 2024 overdose deaths were unintentional, and nearly 47% of 2023 drug overdose deaths in a subset of states involved both opioids and stimulants simultaneously — a dangerous polysubstance trend that complicates both treatment and prevention strategies. The message the mortality data sends is clear: progress is real, but it is fragile.

Opioid Use Disorder Statistics in the US 2026

Opioid Use Disorder Key Indicators — United States 2024

Source: SAMHSA 2024 NSDUH (HHS Publication PEP25-07-007, 2025); CDC NCHS Data Briefs 522 and 549; CDC Understanding the Opioid Overdose Epidemic, updated 2025

Opioid use disorder remains one of the most clinically serious and lethal forms of SUD in the United States. While overdose deaths involving opioids dropped dramatically in 2024, the underlying pool of 4.8 million people with active opioid use disorder remains enormous, and treatment access is alarmingly low. Only 17% — fewer than 1 in 6 people with OUD — received medications for opioid use disorder (MOUD) such as buprenorphine or methadone in the past year, despite these medications being shown to reduce overdose risk, improve treatment retention, and save lives. The cumulative toll of the opioid epidemic from 1999 to 2023 is approximately 806,000 deaths — a staggering generational loss.

The prescription opioid misuse figure of 7.6 million people in 2024 is particularly important because it reflects a population that often begins misuse through legitimately prescribed medications, creating a pipeline from medical exposure to disorder. 42.3% of those who misused prescription pain relievers said they obtained them from a friend or relative, rather than through their own prescription — a finding that highlights the importance of safe medication storage and disposal. The sharp decline in heroin overdose deaths (down 33% from 2022 to 2023) reflects both a shift in the illicit drug supply toward fentanyl and the relative effectiveness of harm reduction strategies focused on naloxone distribution and fentanyl test strips.

Alcohol Use Disorder Statistics in the US 2026

Alcohol Use Disorder and Alcohol Use Patterns — United States 2024

Source: SAMHSA 2024 NSDUH (HHS Publication PEP25-07-007, 2025); Peterson et al., JAMA Network Open, 2021

Alcohol use disorder is the single most common form of substance use disorder in the United States, affecting 27.9 million people aged 12 or older — more than the population of Texas. Despite this staggering scale, only 2.5% of people with alcohol use disorder — roughly 697,000 people — received medications for alcohol use disorder (MAUD) in the past year. This is one of the largest and most troubling treatment gaps in all of U.S. healthcare, particularly given that FDA-approved medications such as naltrexone and acamprosate have a well-documented evidence base. The decline in AUD rates from 10.6% in 2021 to 9.7% in 2024 is modest but statistically significant, and may reflect trends such as the rise of the “sober curious” movement, increased public awareness, and the fact that binge and heavy drinking also declined over this period.

The economic and healthcare burden of alcohol use disorder is substantial. U.S. hospitals incurred an estimated $7.6 billion in alcohol-related care costs in a single year based on analysis of 2017 hospital data — the largest share within the broader $13.2 billion annual SUD hospital cost burden. These are direct medical costs only; they do not include lost productivity, law enforcement, or the incalculable social costs to families. The overall annual economic cost of substance misuse — encompassing alcohol, illicit drugs, and prescription drug misuse — is estimated by NIDA at over $740 billion per year, a figure that dwarfs most other public health expenditures and underscores the return on investment that expanded treatment access could deliver.

SUD Treatment Access and the Treatment Gap in the US 2026

Substance Use Treatment Receipt — United States 2024

Source: SAMHSA 2024 NSDUH (HHS Publication PEP25-07-007, 2025); SAMHSA Press Release, July 2025

The treatment gap for substance use disorder in the United States is one of the most serious and persistent failures in American healthcare. In 2024, approximately 1 in 5 people who needed substance use treatment actually received it — meaning that roughly 4 out of every 5 people with a diagnosable SUD went without professional care. This is not a reflection of personal choice alone. Barriers include lack of insurance coverage, fear of stigma, limited availability of treatment providers, geographic access issues in rural areas, and the simple fact that many people with SUD do not recognize or accept that they need help. The NSDUH data shows that among adults who perceived an unmet need for treatment, many cited cost and lack of coverage as primary obstacles.

The medication treatment gap is even more alarming. For opioid use disorder — one of the most lethal forms of SUD — only 17% of people received MOUD despite broad clinical consensus that medications like buprenorphine and methadone are the gold standard of care. For alcohol use disorder, the gap is even more pronounced: only 2.5% received medications. The silver lining visible in the 2024 data is that telehealth is emerging as a promising access point, with the NSDUH for the first time capturing data on SUD treatment received via telehealth — a modality that expanded significantly following COVID-19. Additionally, among adolescents with co-occurring major depressive episodes and SUD, a relatively high 72.1% received either mental health or substance use treatment, suggesting that integrated care models are making some inroads in younger populations.

SUD and Co-Occurring Mental Health Conditions in the US 2026

Co-Occurring Mental Illness and Substance Use Disorder — Adults, United States 2024

Source: SAMHSA 2024 NSDUH (HHS Publication PEP25-07-007, 2025)

The relationship between substance use disorder and mental illness is one of the most critical — and frequently underrecognized — dimensions of the SUD crisis in the United States. The 2024 NSDUH data reveals that 33% of American adults, or 86.6 million people, had either any mental illness or a substance use disorder in the past year. This is a staggering figure that illustrates how deeply intertwined behavioral health challenges are across the population. SUD and mental illness are highly co-occurring: people living with depression, anxiety, trauma, or psychosis are at significantly elevated risk of developing a substance use disorder, and vice versa. The presence of both conditions simultaneously — known as co-occurring or dual diagnosis — typically requires integrated, coordinated treatment rather than addressing either condition in isolation.

Among adolescents aged 12 to 17 in 2024, 18.8% — nearly 1 in 5 — had moderate or severe symptoms of Generalized Anxiety Disorder (GAD), including 8.2% with severe symptoms. This adolescent anxiety burden, when combined with elevated rates of adolescent substance use experimentation, creates compounding vulnerability. The encouraging finding is that among adolescents with co-occurring major depressive episodes and SUD, 72.1% received some form of treatment, suggesting that mental health screening is acting as an entry point to care. However, 27.9% of this high-risk group received no treatment at all, which represents an urgent area for intervention. Better integration of mental health screening and SUD care — particularly in schools, pediatric practices, and emergency departments — is essential to closing these gaps.

SUD Recovery Statistics in the US 2026

Recovery and Self-Perception of Recovery — United States 2024

Source: SAMHSA 2024 NSDUH (HHS Publication PEP25-07-007, 2025); SAMHSA Blog, July 2025; CDC NCHS, May 2025

Perhaps the most powerful and underreported finding in recent substance use disorder statistics is the recovery rate: among the approximately 30.5 million adults who reported ever perceiving they had a substance use problem, an extraordinary 74.3% — nearly three quarters — considered themselves to be in recovery or to have fully recovered. This finding, highlighted prominently in SAMHSA’s 2024 NSDUH release, is a powerful counter-narrative to the often fatalistic public perception of addiction. Recovery is not the exception — it is the norm for people who engage with treatment, peer support, and community resources. Similarly, among the 67.8 million adults who felt they had ever had a mental health problem, 66.9% considered themselves recovered — demonstrating that the brain conditions underlying both SUD and mental illness are genuinely responsive to care.

The geographic progress in overdose deaths reinforces this recovery picture at the population level. 45 out of 50 states recorded declines in overdose deaths in 2024, some exceeding 35%. The continued decline projected through late 2025 — with predicted overdose deaths falling to approximately 71,542 for the 12 months ending October 2025 — suggests that increased availability of naloxone, expansion of medications for OUD, growth in harm reduction programs, and law enforcement actions against fentanyl supply chains are collectively having a measurable life-saving effect. The trajectory is encouraging, but the baseline remains deeply troubling: over 70,000 Americans are still dying every year from drug overdoses, and the vast majority of those deaths are preventable. Sustained investment in prevention, treatment, and recovery support infrastructure remains the defining public health imperative of this era.

Disclaimer: The data reports published on The Global Files are sourced from publicly available materials considered reliable. While efforts are made to ensure accuracy, no guarantees are provided regarding completeness or reliability. The Global Files is not liable for any errors, omissions, or damages resulting from the use of these reports.